TTF1 and adenocarcinoma: In non-small-cell carcinomas, whose direction of differentiation cannot be identified on morphological examination, tumors that test positive for TTF-1 should be reclassified as NSCLC, inclined towards adenocarcinomas, regardless of the co-expression of squamous cell carcinoma.